Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
Article excerpt
Highlighted: the sentence this signal was extracted from
The new platform brings together advanced analysis, purpose-built AI, and curated biological data so researchers can move more quickly from complex genomic and multiomic data to actionable insight Included in the new platform, latest DRAGEN update expands access to Illumina's award-winning secondary analysis across supported cloud and standard computing environment SAN DIEGO , Oct. 14, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN ) today debuted the Illumina BioInsight Platform, the company's first unified software environment designed to help researchers turn complex genomic and multiomic data into meaningful biological evidence. By bringing together Illumina's analysis applications, purpose-built AI innovations, and curated data resources in one environment, the platform delivers flexibility and accessibility, while reducing the need to assemble and manage separate informatics tools as research questions evolve. "BioInsight was built on an incredible history of data, software, and AI innovation that Illumina has delivered in the industry for more than a decade," said Rami Mehio, senior vice president and general manager of BioInsight at Illumina. "Now, BioInsight is accelerating our pace of innovation, and with the BioInsight Platform we are bringing customers one simple place to access the full breadth of our offerings across software, AI, and data. And the best part...
Keep reading with a free account
The rest of this article, and every signal for Illumina, is in your free account.